Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

2.

Re: Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

Alcaraz A, Mengual L.

Eur Urol. 2018 Sep;74(3):397. doi: 10.1016/j.eururo.2018.03.038. Epub 2018 Apr 12. No abstract available.

PMID:
29656853
3.
4.

Meeting Report From the Prostate Cancer Foundation Scientific Working Group on Radium-223.

Miyahira AK, Morris M, Soule HR; PCF Radium-223 Scientific Working Group.

Prostate. 2017 Feb;77(3):245-254. doi: 10.1002/pros.23272. Epub 2016 Nov 1. Review.

PMID:
27800631
6.

Prostate cancer risk assessment program. A model for the early detection of prostate cancer.

Bruner DW, Baffoe-Bonnie A, Miller S, Diefenbach M, Tricoli JV, Daly M, Pinover W, Grumet SC, Stofey J, Ross E, Raysor S, Balshem A, Malick J, Engstrom P, Hanks GE, Mirchandani I.

Oncology (Williston Park). 1999 Mar;13(3):325-34; discussion 337-9, 343-4 pas.

7.

Real-life patient testimonials, nickname promote Thomas Jefferson University Hospital.

[No authors listed]

Profiles Healthc Commun. 2006 Jul-Aug;22(4):1, 4-9, 2.

PMID:
16922251
8.

Living donation: focus on public concerns.

Zink S, Weinreib R, Sparling T, Caplan AL.

Clin Transplant. 2005 Oct;19(5):581-5. Review.

PMID:
16146547
9.

National implementation of multi-parametric magnetic resonance imaging for prostate cancer detection - recommendations from a UK consensus meeting.

Brizmohun Appayya M, Adshead J, Ahmed HU, Allen C, Bainbridge A, Barrett T, Giganti F, Graham J, Haslam P, Johnston EW, Kastner C, Kirkham APS, Lipton A, McNeill A, Moniz L, Moore CM, Nabi G, Padhani AR, Parker C, Patel A, Pursey J, Richenberg J, Staffurth J, van der Meulen J, Walls D, Punwani S.

BJU Int. 2018 Jul;122(1):13-25. doi: 10.1111/bju.14361. Epub 2018 Jun 5.

10.

Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping.

Schwartz GF, Reis-Fihlo J, Pusztai L, Fentiman IS, Holland R, Bartelink H, Rutgers EJ, Solin LJ, Palazzo J; Consensus Committee.

Cancer. 2012 Apr 15;118(8):2031-8. doi: 10.1002/cncr.27431. Epub 2012 Mar 5.

11.

Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017.

Chiong E, Murphy DG, Akaza H, Buchan NC, Chung BH, Kanesvaran R, Khochikar M, Letran J, Lojanapiwat B, Ng CF, Ong T, Pu YS, Saad M, Schubach K, Türkeri L, Umbas R, Le Chuyen V, Williams S, Ye DW; ANZUP Cancer Trials Group, Davis ID.

BJU Int. 2019 Jan;123(1):22-34. doi: 10.1111/bju.14489. Epub 2018 Aug 19. Review.

12.

How I Do It: Genetic counseling and genetic testing for inherited prostate cancer.

Giri VN, Gross L, Gomella LG, Hyatt C.

Can J Urol. 2016 Apr;23(2):8247-53. Review.

14.

Commentary on: "Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial." Kwon ED, Drake CG, Scher HI, Fizazi K, Bossi A, van den Eertwegh AJ, Krainer M, Houede N, Santos R, Mahammedi H, Ng S, Maio M, Franke FA, Sundar S, Agarwal N, Bergman AM, Ciuleanu TE, Korbenfeld E, Sengeløv L, Hansen S, Logothetis C, Beer TM, McHenry MB, Gagnier P, Liu D, Gerritsen WR, CA184-043 Investigators. Departments of Urology and Immunology and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA, Electronic address: kwon.eugene@mayo.edu; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Brady Urological Institute, Baltimore, MD, USA; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA; Institut Gustave Roussy, University of Paris-Sud, Villejuif, France; Institut Gustave Roussy, Villejuif, France; VU University Medical Centre, Amsterdam, Netherlands; Vienna General Hospital, Medical University Vienna, Vienna, Austria; Institut Bergonié, Bordeaux, France; CHU Caremeau, Nimes, France; Centro Médico Austral, Buenos Aires, Argentina; Centre Jean Perrin, Clermont-Ferrand, France; St John of God Hospital, Subiaco, WA, Australia; University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy; Hospital de Caridade de Ijuí, Ijuí, Brazil; Nottingham University Hospital, Nottingham, UK; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Institute of Oncology Ion Chiricuta and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania; Hospital Británico de Buenos Aires, Buenos Aires, Argentina; Herlev Hospital, Herlev, Denmark; Odense University Hospital, Odense, Denmark; University of Texas MD Anderson Cancer Center, Houston,

Trump D.

Urol Oncol. 2016 May;34(5):249-50. doi: 10.1016/j.urolonc.2015.03.013. Epub 2015 Apr 20.

PMID:
25907621
15.

Focal therapy in prostate cancer: international multidisciplinary consensus on trial design.

van den Bos W, Muller BG, Ahmed H, Bangma CH, Barret E, Crouzet S, Eggener SE, Gill IS, Joniau S, Kovacs G, Pahernik S, de la Rosette JJ, Rouvière O, Salomon G, Ward JF, Scardino PT.

Eur Urol. 2014 Jun;65(6):1078-83. doi: 10.1016/j.eururo.2014.01.001. Epub 2014 Jan 13.

PMID:
24444476
17.

Therapeutic targeting of prostate cancer.

Cress AE, Mohla S.

Cancer Biol Ther. 2004 Oct;3(10):1028-30. Epub 2004 Oct 15.

PMID:
15539935
18.

Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting.

Luo J, Attard G, Balk SP, Bevan C, Burnstein K, Cato L, Cherkasov A, De Bono JS, Dong Y, Gao AC, Gleave M, Heemers H, Kanayama M, Kittler R, Lang JM, Lee RJ, Logothetis CJ, Matusik R, Plymate S, Sawyers CL, Selth LA, Soule H, Tilley W, Weigel NL, Zoubeidi A, Dehm SM, Raj GV.

Eur Urol. 2018 May;73(5):715-723. doi: 10.1016/j.eururo.2017.11.038. Epub 2017 Dec 16. Review.

19.

The European Prostate Cancer Centres of Excellence: A Novel Proposal from the European Association of Urology Prostate Cancer Centre Consensus Meeting.

Wirth M, Fossati N, Albers P, Bangma C, Brausi M, Comperat E, Faithfull S, Gillessen S, Jereczek-Fossa BA, Mastris K, Mottet N, Müller SC, Pieters B, Ribal MJ, Sangar V, Schoots IG, Smelov V, Travado L, Valdagni R, Wesselmann S, Wiegel T, van Poppel H.

Eur Urol. 2019 Aug;76(2):179-186. doi: 10.1016/j.eururo.2019.01.033. Epub 2019 Feb 22.

PMID:
30799188
20.

Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations.

Mukherji D, Youssef B, Dagher C, El-Hajj A, Nasr R, Geara F, Rabah D, Al Dousari S, Said R, Ashou R, Wazzan W, Jabbour M, Farha G, Al Hamdani N, Al Hallaq Y, Ghazal H, Dbouk H, Bachir B, El Khoury C, Sakr G, Hussain HK, Sayyid K, Ibrahim K, Haidar M, Zouain N, Bitar N, Alameh W, Abbas F, Faddoul S, Nemer E, Assaf G, Farhat F, Bulbul M, Temraz S, Shamseddine A, Gillessen S, Omlin A, Khauli R.

World J Urol. 2019 Jul 11. doi: 10.1007/s00345-019-02872-x. [Epub ahead of print]

PMID:
31297628

Supplemental Content

Support Center